← Company directory

Other / review

OrganOx

Medical devices — normothermic organ (liver) perfusion technology

VerifiedEquity financing, 2nd private-placement closing (same program as above, incremental new money — not a fresh priced round)Oxford
Companies House
06557113
GLEIF LEI
Not matched
Latest evidence
2025-05-08
Evidence snapshot
2026-08-25
Funding signal8

Dated disclosed rounds · latest 2025-05-08

Procurement signal0

Exact award notices · latest No exact award match

Registry observationMatched

2026-08-25T03:23:50.893Z

Regional contextSouth East

Jun 2026

Signals organise dated evidence; they do not score growth, revenue, creditworthiness or investment performance.

Evidence timeline

10 dated observations

Funding, procurement, registry and identifier records are placed on one chronology. Each row says whether it is a source fact, a record observation or reference metadata; no inferred event is inserted.

  1. RegistryRecord observation

    Status observed: Active

    Snapshot evidence only; this row does not claim the status changed on this date.

  2. FundingSource fact

    BGF follow-on

    £4.6M (~$5.36M) · 1 named investor

    VC research snapshot; Live Chris T D1funding_id joined to resolved canonical company · published
  3. FundingSource fact

    Follow-on round (label uncertain — inferred later 'Series B'-equivalent by sequence, not an explicit company label)

    just under £1 million (imprecise per source) · 2 named investors

    VC research snapshot; Live Chris T D1funding_id joined to resolved canonical company · published
  4. RegistryRegistry fact

    Company incorporated

    ORGANOX LIMITED · company 06557113

Latest disclosed round

Equity financing, 2nd private-placement closing (same program as above, incremental new money — not a fresh priced round)

Date
2025-05-08
Amount
USD 18m
Sector
Healthtech & digital health; Deeptech / hardware
Companies House
06557113
ONS region
South East

Evidence status

Directory ready

Identity
Verified
Match
High — exact company number and aligned registered name
Operating status
active
Data origins
Core directory, Live Chris T D1

Capital network

11 linked investors

Lead, participant, lender and other retained roles remain distinct where the source supports them. Every relationship below names its source layer, observation date, match method and publication state.

InvestorRoleDateSourceMatch / state
BGFlead2020-01-08Bgf ↗reviewed canonical company and investor alias resolutionsource-linked · published
HealthQuest Capital (new)lead2025-02-24Globenewswire ↗ · Lw ↗reviewed canonical company and investor alias resolutionsource-linked · published
Lauxera Capital Partnerslead2023-07-17Globenewswire ↗reviewed canonical company and investor alias resolutionsource-linked · published
Longwall Venture Partners (continuinglead2013-2014VC research snapshot; Live Chris T D1 · no retained URLreviewed canonical company and investor alias resolutionsource-linked · published
no lead explicitly named)lead2013-2014VC research snapshot; Live Chris T D1 · no retained URLreviewed canonical company and investor alias resolutionsource-linked · published
Oxford Technology Management Ltd (later Longwall Ventures)lead2008Ac ↗reviewed canonical company and investor alias resolutionsource-linked · published
Technikoslead2008Ac ↗reviewed canonical company and investor alias resolutionsource-linked · published
University Challenge Seed Fundlead2008Ac ↗reviewed canonical company and investor alias resolutionsource-linked · published
Existing investors (not individually named in the release)participant2023-07-17Globenewswire ↗reviewed canonical company and investor alias resolutionsource-linked · published
Existing: BGF (£20M of this round specifically), Lauxera Capital Partners, University of Oxford, Technikos, Oxford Technology and Innovations Fund, Longwall Ventures. New: Sofina, Soleus Capital, Avidity Partnersparticipant2025-02-24Globenewswire ↗ · Lw ↗reviewed canonical company and investor alias resolutionsource-linked · published
New: Intuitive Ventures, Terumo Ventures, Piper Heartland Healthcare LLCparticipant2025-05-08Globenewswire ↗reviewed canonical company and investor alias resolutionsource-linked · published

Funding record

8 disclosed rounds

Open a dated round to move directly between the company, named investors and source publication.

DateStageAmountInvestorsNamed sources
2025-05-08Equity financing, 2nd private-placement closing (same program as above, incremental new money — not a fresh priced round)~$18M incremental (brought the financing program's cumulative total to $160M)New: Intuitive Ventures, Terumo Ventures, Piper Heartland Healthcare LLCGlobenewswire ↗
2025-02-24Equity financing, 1st closing$142MHealthQuest Capital (new) · Existing: BGF (£20M of this round specifically), Lauxera Capital Partners, University of Oxford, Technikos, Oxford Technology and Innovations Fund, Longwall Ventures. New: Sofina, Soleus Capital, Avidity PartnersGlobenewswire ↗ · Lw ↗
2023-07-17Growth round (aggregators label this 'Series D')£25M (reported as $32.6-32.7M)Lauxera Capital Partners · Existing investors (not individually named in the release)Globenewswire ↗
2020-01-08BGF follow-on£4.6M (~$5.36M)BGF
2019BGF first investment (label uncertain — inferred later 'Series C'-equivalent by sequence)undisclosedBGFBgf ↗
2013-2014Follow-on round (label uncertain — inferred later 'Series B'-equivalent by sequence, not an explicit company label)just under £1 million (imprecise per source)Longwall Venture Partners (continuing · no lead explicitly named)
2008Seed / proof-of-concept£250,000University Challenge Seed FundAc ↗
2008Early round (Oxford University Innovation calls it 'seed'; one outlet's headline calls it 'Series A')£1.5MTechnikos · Oxford Technology Management Ltd (later Longwall Ventures)Ac ↗

Companies House status and filing snapshot

ORGANOX LIMITED

Exact company-number match from the public register. The retained status is active. Filing dates and SIC codes are registry context, not a credit or investment-quality assessment.

Registered record

Status
Active
Company type
Private Limited Company
Country of origin
United Kingdom
Incorporated
2008-04-07
Dissolved
Not applicable
Company number
06557113

Filing context

Accounts category
GROUP
Accounts made up to
2024-12-31
Next accounts due
2026-12-31
Confirmation made up to
2026-04-07
Registry snapshot
2026-08-01
Live check
2026-08-25T03:23:50.893Z
72190Other research and experimental development on natural sciences and engineering

SourceCompanies HouseDate2026-08-25T03:23:50.893ZMatchexact Companies House numberStatepublished projection

CompanyBeacon statutory projection

ORGANOX LIMITED

UK Capital Intelligence owns the capital view on this page. CompanyBeacon owns the exact legal-entity, filing, control and public-record timeline for company number 06557113.

Latest retained status

active

Checked
2026-08-25T03:23:50.893Z
Recorded change
No change timestamp retained
Previous status
active
Fund associations
1 dated CompanyBeacon membership

Boundary

Verify the legal record

Fund association does not prove a current holding. Status change is a review signal, not investment performance or wrongdoing. Ownership and control are not copied into this public UKCI package.

Open CompanyBeacon record ↗

SourceCompanyBeaconDate2026-08-25T03:23:50.893ZMatchexact_company_numberStatepublished_projection

Traceability

Source trail

Funding and investor claims retain named public-source links. This is a dated research snapshot, not a live cap table.